---
title: "Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275035118.md"
description: "Bristol Myers Squibb Co. (BMY) shares rose 3.30% to $59.52 on a challenging trading day for the market, with the S&P 500 and Dow Jones falling 1.23% and 1.20%, respectively. This marks the fifth consecutive day of gains for BMY, which is currently 6.02% below its 52-week high of $63.33. The stock outperformed competitors like Johnson & Johnson, Pfizer, and Abbott Laboratories. Trading volume reached 23.9 million, surpassing the 50-day average of 14.6 million."
datetime: "2026-02-05T21:39:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275035118.md)
  - [en](https://longbridge.com/en/news/275035118.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275035118.md)
generator: "portal-rs"
---

# Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. (BMY) advanced 3.30% to $59.52 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.23% to 6,798.40 and Dow Jones Industrial Average falling 1.20% to 48,908.72.

This was the stock's fifth consecutive day of gains.

Bristol Myers Squibb Co. closed 6.02% below its 52-week high of $63.33, which the company achieved on March 11th.

The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 1.42% to $237.79, Pfizer Inc. (PFE) fell 1.08% to $26.49, and Abbott Laboratories (ABT) rose 0.81% to $109.08.

Trading volume (23.9 M) eclipsed its 50-day average volume of 14.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 5, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

02-05-26 1639ET

### Related Stocks

- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABL.US](https://longbridge.com/en/quote/ABL.US.md)

## Related News & Research

- [BUZZ-J&J gains after report says Apollo in talks for company's orthopedics unit](https://longbridge.com/en/news/298910491.md)
- [NEOS Investment Management LLC Buys 38,043 Shares of Johnson & Johnson $JNJ](https://longbridge.com/en/news/298824702.md)
- [Johnson & Johnson $JNJ Shares Sold by B. Metzler seel. Sohn & Co. AG](https://longbridge.com/en/news/298796355.md)
- [Abbott to pay $384 million over contaminated infant formula allegations, US Justice Dept says](https://longbridge.com/en/news/298950554.md)
- [STEIN MITCHELL ATTORNEYS REPRESENT WHISTLEBLOWERS IN NEARLY $385 MILLION ABBOTT INFANT FORMULA SETTLEMENT](https://longbridge.com/en/news/298961296.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**